{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:30:19Z","timestamp":1792852219583,"version":"4.5.0"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Cholangiocarcinoma (CCA) is a highly aggressive malignancy of the biliary epithelium, with its incidence and mortality rates continuing to rise worldwide. Advances in high-throughput sequencing and metabolomic technologies have intensified interest in elucidating the role of the microbiome in CCA. Microbial dysbiosis may contribute to tumor initiation and progression by inducing chronic inflammation, altering metabolic pathways, and modulating the immune microenvironment. Moreover, these microbial alterations have been associated with therapeutic resistance, underscoring their potential impact on disease progression and treatment outcomes. This review summarizes the potential origins of intratumoral microorganisms and the microbiome alterations associated with distinct CCA subtypes. Crucially, we critically evaluate the methodological challenges inherent to low-biomass biliary samples\u2014including contamination risks and confounding factors such as cholestasis and medical interventions\u2014and distinguish between associative and causal evidence in current literature. Collectively, this work aims to provide a rigorous theoretical framework and novel insights for microbiome-based strategies in the early diagnosis and treatment of CCA.<\/jats:p>","DOI":"10.3389\/fmicb.2026.1727736","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:39:31Z","timestamp":1769495971000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Microbial dysbiosis in cholangiocarcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Yunjia","family":"Liu","sequence":"first","affiliation":[{"name":"Department of General Surgery, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s12223-025-01342-9","article-title":"Phage therapy and its role in cancer treatment and control","volume":"70","author":"Abd El-Moaty","year":"2025","journal-title":"Folia Microbiol. (Praha)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.chom.2016.07.006","article-title":"Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc","volume":"20","author":"Abed","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/978-1-0716-2445-6_32","article-title":"Progress and challenges in studying the ecophysiology of Archaea","volume":"2522","author":"Adam","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/acs.chemrev.2c00431","article-title":"Microbiome and human health: current understanding, engineering, and enabling technologies","volume":"123","author":"Aggarwal","year":"2023","journal-title":"Chem. Rev."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e0040825","DOI":"10.1128\/msystems.00408-25","article-title":"Impact of study design, contamination, and data characteristics on results and interpretation of microbiome studies","volume":"10","author":"Agudelo","year":"2025","journal-title":"mSystems"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.tibtech.2024.09.002","article-title":"Phage-guided nanocarriers: a precision strategy against bacterial pathogens","volume":"43","author":"Ahmed","year":"2025","journal-title":"Trends Biotechnol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.7150\/jca.59251","article-title":"Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients","volume":"12","author":"Ali","year":"2021","journal-title":"J. Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e88043","DOI":"10.7759\/cureus.88043","article-title":"Post-endoscopic retrograde cholangiopancreatography (ERCP) complications: A systematic review of microbial patterns, incidence, risk factors, and management strategies in contemporary practice","volume":"17","author":"Al-Kabban","year":"2025","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.12938\/bmfh.19-023","article-title":"Interaction of the microbiota with the human body in health and diseases","volume":"39","author":"Altve\u015f","year":"2020","journal-title":"Biosci. Microbiota Food Health"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/hep.32135","article-title":"Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas","volume":"75","author":"An","year":"2022","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"105430","DOI":"10.1016\/j.jprot.2025.105430","article-title":"The dawn of the revolution that will allow us to precisely describe how microbiomes function","volume":"316","author":"Armengaud","year":"2025","journal-title":"J. Proteome"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1093\/nar\/gkaa856","article-title":"Seeker: alignment-free identification of bacteriophage genomes by deep learning","volume":"48","author":"Auslander","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40168-025-02048-3","article-title":"Challenges in capturing the mycobiome from shotgun metagenome data: lack of software and databases","volume":"13","author":"Avershina","year":"2025","journal-title":"Microbiome"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"178.e11","DOI":"10.1016\/j.cmi.2015.10.008","article-title":"Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma","volume":"22","author":"Avil\u00e9s-Jim\u00e9nez","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","article-title":"The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL","volume":"574","author":"Aykut","year":"2019","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","author":"B\u00e4ckhed","year":"2005","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.ccell.2021.10.010","article-title":"Mechanistic dissection unmasks colibactin as a prevalent mutagenic driver of cancer","volume":"39","author":"Berger","year":"2021","journal-title":"Cancer Cell"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","article-title":"Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver","volume":"39","author":"Bertocchi","year":"2021","journal-title":"Cancer Cell"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3322\/caac.21398","article-title":"The role of the microbiome in cancer development and therapy","volume":"67","author":"Bhatt","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41577-023-00951-0","article-title":"Role of the microbiota in response to and recovery from cancer therapy","volume":"24","author":"Blake","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1016\/j.csbj.2020.11.049","article-title":"Measuring the microbiome: best practices for developing and benchmarking microbiomics methods","volume":"18","author":"Bokulich","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1477-2574.2011.00423.x","article-title":"Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation","volume":"14","author":"Boonyanugomol","year":"2012","journal-title":"HPB (Oxford)"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"128392","DOI":"10.1016\/j.micres.2025.128392","article-title":"The hidden players: the mycobiome of pancreatic ductal adenocarcinoma tumors","volume":"303","author":"Camille","year":"2026","journal-title":"Microbiol. Res."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5946\/ce.2024.270","article-title":"Fecal microbiota transplantation: present and future","volume":"58","author":"Cha","year":"2025","journal-title":"Clin. Endosc."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2156255","DOI":"10.1080\/19490976.2022.2156255","article-title":"Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma","volume":"15","author":"Chai","year":"2023","journal-title":"Gut Microbes"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1007\/s00253-018-8871-2","article-title":"Methanogens in humans: potentially beneficial or harmful for health","volume":"102","author":"Chaudhary","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1092563","DOI":"10.1155\/2019\/1092563","article-title":"A preliminary study of biliary microbiota in patients with bile duct stones or distal cholangiocarcinoma","volume":"2019","author":"Chen","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1281745","DOI":"10.3389\/fcimb.2023.1281745","article-title":"Profiles of biliary microbiota in biliary obstruction patients with Clonorchis sinensis infection","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e1481","DOI":"10.1002\/ctm2.1481","article-title":"H. pylori-induced NF-\u03baB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1288525","DOI":"10.3389\/fmicb.2023.1288525","article-title":"Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/ijc.32003","article-title":"Fecal microbiota transplantation in cancer management: current status and perspectives","volume":"145","author":"Chen","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3727\/105221618x15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ebiom.2016.04.034","article-title":"Tissue microbiome profiling identifies an enrichment of specific enteric Bacteria in Opisthorchis viverrini associated cholangiocarcinoma","volume":"8","author":"Chng","year":"2016","journal-title":"EBioMedicine"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/14737159.2018.1544495","article-title":"The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine","volume":"18","author":"Choy","year":"2018","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1172\/jci155101","article-title":"Colorectal cancer: the facts in the case of the microbiota","volume":"132","author":"Clay","year":"2022","journal-title":"J. Clin. Invest."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-4939-7471-9_5","article-title":"Microbiome sequencing methods for studying human diseases","volume":"1706","author":"Davidson","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-Resistant E. coli bacteremia transmitted by fecal microbiota transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.chom.2020.12.001","article-title":"The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants","volume":"29","author":"Dohlman","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2185028","DOI":"10.1080\/19490976.2023.2185028","article-title":"Intestinal bacteria and colorectal cancer: etiology and treatment","volume":"15","author":"Dougherty","year":"2023","journal-title":"Gut Microbes"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41591-020-0908-2","article-title":"Colibactin DNA-damage signature indicates mutational impact in colorectal cancer","volume":"26","author":"Dziuba\u0144ska-Kusibab","year":"2020","journal-title":"Nat. Med."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","article-title":"Contamination in low microbial biomass microbiome studies: issues and recommendations","volume":"27","author":"Eisenhofer","year":"2019","journal-title":"Trends Microbiol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","article-title":"Characterization of animal models for primary sclerosing cholangitis (PSC)","volume":"60","author":"Fickert","year":"2014","journal-title":"J. Hepatol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41564-025-02035-2","article-title":"Guidelines for preventing and reporting contamination in low-biomass microbiome studies","volume":"10","author":"Fierer","year":"2025","journal-title":"Nat. Microbiol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/s41586-023-06292-1","article-title":"Revisiting the intrinsic mycobiome in pancreatic cancer","volume":"620","author":"Fletcher","year":"2023","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/genes16080920","article-title":"Genomic alterations and microbiota crosstalk in hepatic cancers: the gut-liver Axis in tumorigenesis and therapy","volume":"16","author":"Fu","year":"2025","journal-title":"Genes (Basel)"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1172\/jci184321","article-title":"The gut microbiome and cancer response to immune checkpoint inhibitors","volume":"135","author":"Gazzaniga","year":"2025","journal-title":"J. Clin. Invest."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","article-title":"Immunology and immunotherapy of cholangiocarcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1556361","DOI":"10.3389\/fbinf.2025.1556361","article-title":"micRoclean: an R package for decontaminating low-biomass 16S-rRNA microbiome data","volume":"5","author":"Griffard-Smith","year":"2025","journal-title":"Front. Bioinform."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"625589","DOI":"10.3389\/fcimb.2021.625589","article-title":"Biliary microbiota in Choledocholithiasis and correlation with duodenal microbiota","volume":"11","author":"Han","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1128\/mBio.02248-18","article-title":"Diagnostic potential and interactive dynamics of the colorectal cancer virome","volume":"9","author":"Hannigan","year":"2018","journal-title":"MBio"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.suc.2024.04.003","article-title":"Cholangiocarcinoma","volume":"104","author":"Harrison","year":"2024","journal-title":"Surg. Clin. North Am."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/gutjnl-2018-317200","article-title":"Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin","volume":"68","author":"He","year":"2019","journal-title":"Gut"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tim.2017.11.002","article-title":"Human gut microbiome: function matters","volume":"26","author":"Heintz-Buschart","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","article-title":"The microbiome, cancer, and cancer therapy","volume":"25","author":"Helmink","year":"2019","journal-title":"Nat. Med."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","article-title":"The microbiota and the gut-liver axis in primary sclerosing cholangitis","volume":"20","author":"Hov","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41522-025-00819-2","article-title":"Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors","volume":"11","author":"Huang","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.ccell.2025.05.017","article-title":"Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma","volume":"43","author":"Huang","year":"2025","journal-title":"Cancer Cell"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.euf.2024.12.007","article-title":"Best practice guidelines for collecting microbiome samples in research studies","volume":"10","author":"Isali","year":"2024","journal-title":"Eur. Urol. Focus"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215379","article-title":"Dysbiosis of the fecal and biliary microbiota in biliary tract Cancer","volume":"14","author":"Ito","year":"2022","journal-title":"Cancers (Basel)"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/hep.30852","article-title":"Characterization of gut microbiota, bile acid metabolism, and cytokines in intrahepatic cholangiocarcinoma","volume":"71","author":"Jia","year":"2020","journal-title":"Hepatology"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.cell.2024.02.022","article-title":"Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer","volume":"187","author":"Jia","year":"2024","journal-title":"Cell"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","article-title":"Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer","volume":"31","author":"Jiang","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"a27333468","DOI":"10.1055\/a-2733-3468","article-title":"Biliary stents reshape the bile microbiome in the absence of cholangitis","volume":"13","author":"Kayashima","year":"2025","journal-title":"Endosc. Int. Open"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3350\/cmh.2024.1039","article-title":"Unveiling the Intratumor microbiome in liver Cancer: current insights and prospective applications","volume":"31","author":"Ke","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.suc.2018.12.004","article-title":"Cholangiocarcinoma","volume":"99","author":"Khan","year":"2019","journal-title":"Surg. Clin. North Am."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.tim.2020.05.021","article-title":"Challenges of studying the human Virome - relevant emerging technologies","volume":"29","author":"Khan Mirzaei","year":"2021","journal-title":"Trends Microbiol."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40168-017-0267-5","article-title":"Optimizing methods and dodging pitfalls in microbiome research","volume":"5","author":"Kim","year":"2017","journal-title":"Microbiome"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"15780","DOI":"10.1038\/s41598-025-99980-z","article-title":"Melatonin attenuates Helicobacter pylori-mediated cholangiocarcinoma-associated fibroblast activation via modulating integrin\/FAK signaling pathway","volume":"15","author":"Klungsaeng","year":"2025","journal-title":"Sci. Rep."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/qco.0000000000000958","article-title":"Gut microbiome and its clinical implications: exploring the key players in human health","volume":"36","author":"Koneru","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"11772719241287400","DOI":"10.1177\/11772719241287400","article-title":"Biomarkers from discovery to clinical application: in silico pre-clinical validation approach in the face of lung Cancer","volume":"19","author":"Kori","year":"2024","journal-title":"Biomark. Insights"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"151421","DOI":"10.1016\/j.bbrc.2025.151421","article-title":"Helicobacter pylori virulence factor CagA promotes snail-mediated epithelial-mesenchymal transition and invasive behavior by downregulating Semaphorin 5A in gastric epithelial cells","volume":"750","author":"Kubo","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"642311","DOI":"10.3389\/fcimb.2021.642311","article-title":"Editorial: tissue remodeling in health and disease caused by Bacteria, parasites, Fungi, and viruses","volume":"11","author":"Lange","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3390\/life14060698","article-title":"Beyond the bile: exploring the microbiome and metabolites in cholangiocarcinoma","volume":"14","author":"Lee","year":"2024","journal-title":"Life (Basel)"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12957-020-1793-3","article-title":"16S rDNA microbiome composition pattern analysis as a diagnostic biomarker for biliary tract cancer","volume":"18","author":"Lee","year":"2020","journal-title":"World J. Surg. Oncol."},{"key":"ref77","first-page":"2962","article-title":"Characteristics of bile microbiota in cholelithiasis, perihilar cholangiocarcinoma, distal cholangiocarcinoma, and pancreatic cancer","volume":"14","author":"Li","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1053\/j.gastro.2024.10.023","article-title":"Multi-cohort analysis reveals altered Archaea in colorectal Cancer fecal samples across populations","volume":"168","author":"Li","year":"2025","journal-title":"Gastroenterology"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"2205386","DOI":"10.1080\/19490976.2023.2205386","article-title":"Performance of gut microbiome as an independent diagnostic tool for 20 diseases: cross-cohort validation of machine-learning classifiers","volume":"15","author":"Li","year":"2023","journal-title":"Gut Microbes"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s43018-025-00910-9","article-title":"Microbiome dysbiosis, neutrophil recruitment and mesenchymal transition of mesothelial cells promotes peritoneal metastasis of colorectal cancer","volume":"6","author":"Li","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"2310196","DOI":"10.1080\/07853890.2024.2310196","article-title":"Advances in targeted therapy of cholangiocarcinoma","volume":"56","author":"Li","year":"2024","journal-title":"Ann. Med."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"2452277","DOI":"10.1080\/19490976.2025.2452277","article-title":"From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy","volume":"17","author":"Lin","year":"2025","journal-title":"Gut Microbes"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"101467","DOI":"10.1016\/j.jhepr.2025.101467","article-title":"Blood and tissue dysregulated bile acids and short-chain fatty acids in cholangiocarcinoma","volume":"7","author":"Liu","year":"2025","journal-title":"JHEP Rep."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.ajpath.2018.05.015","article-title":"Conjugated bile acids promote invasive growth of esophageal adenocarcinoma cells and Cancer stem cell expansion via sphingosine 1-phosphate receptor 2-mediated yes-associated protein activation","volume":"188","author":"Liu","year":"2018","journal-title":"Am. J. Pathol."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40364-022-00381-5","article-title":"Intratumor microbiome in cancer progression: current developments, challenges and future trends","volume":"10","author":"Liu","year":"2022","journal-title":"Biomark. Res."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-024-03034-7","article-title":"Unveiling the gastric microbiota: implications for gastric carcinogenesis, immune responses, and clinical prospects","volume":"43","author":"Liu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"101488","DOI":"10.1016\/j.xcrm.2024.101488","article-title":"Intratumor microbiome-derived butyrate promotes lung cancer metastasis","volume":"5","author":"Ma","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"107091","DOI":"10.1016\/j.micpath.2024.107091","article-title":"The oncomicrobiome: new insights into microorganisms in cancer","volume":"197","author":"Ma","year":"2024","journal-title":"Microb. Pathog."},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/liv.15466","article-title":"Association of gut microbiome and primary liver cancer: A two-sample Mendelian randomization and case-control study","volume":"43","author":"Ma","year":"2023","journal-title":"Liver Int."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1080\/17425247.2022.2094363","article-title":"Phage in cancer treatment - biology of therapeutic phage and screening of tumor targeting peptide","volume":"19","author":"Manivannan","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13091980","article-title":"Microbial landscapes of the gut-biliary Axis: implications for benign and malignant biliary tract diseases","volume":"13","author":"Meacci","year":"2025","journal-title":"Microorganisms"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41575-025-01041-3","article-title":"A consensus statement on establishing causality, therapeutic applications and the use of preclinical models in microbiome research","volume":"22","author":"Metwaly","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"111619","DOI":"10.1016\/j.biopha.2021.111619","article-title":"Role of microbiota-derived short-chain fatty acids in cancer development and prevention","volume":"139","author":"Mirzaei","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092120","article-title":"Potential role of inflammation-promoting biliary microbiome in primary Sclerosing cholangitis and cholangiocarcinoma","volume":"14","author":"Miyabe","year":"2022","journal-title":"Cancers (Basel)"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1194\/jlr.R069286","article-title":"The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases","volume":"57","author":"Nagahashi","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4166\/kjg.2023.135","article-title":"Microbiome and biliary tract Cancer","volume":"83","author":"Park","year":"2024","journal-title":"Korean J. Gastroenterol."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"e1260","DOI":"10.1002\/mbo3.1260","article-title":"Impact of antibiotics on the human microbiome and consequences for host health","volume":"11","author":"Patangia","year":"2022","journal-title":"Microbiology"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.4081\/idr.2014.5147","article-title":"A patient presenting with cholangitis due to Stenotrophomonas Maltophilia and Pseudomonas aeruginosa successfully treated with Intrabiliary Colistine","volume":"6","author":"P\u00e9rez","year":"2014","journal-title":"Infect. Dis. Rep."},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214245","article-title":"Bacteriophage-mediated Cancer gene therapy","volume":"23","author":"Petrov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1016\/j.cell.2025.06.018","article-title":"Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy","volume":"188","author":"Phelps","year":"2025","journal-title":"Cell"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1096\/fj.13-232751","article-title":"Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome","volume":"27","author":"Plieskatt","year":"2013","journal-title":"FASEB J."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/mco2.22","article-title":"Pulmonary Staphylococcus aureus infection regulates breast cancer cell metastasis via neutrophil extracellular traps (NETs) formation","volume":"1","author":"Qi","year":"2020","journal-title":"MedComm"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/meg.0000000000002948","article-title":"Distinct composition and metabolic potential of biliary microbiota in patients with malignant bile duct obstruction","volume":"37","author":"Qian","year":"2025","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"e2205563","DOI":"10.1002\/advs.202205563","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal Cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"107064","DOI":"10.1016\/j.ejso.2023.107064","article-title":"Epidemiology of cholangiocarcinoma","volume":"51","author":"Qurashi","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"715536","DOI":"10.3389\/fphys.2021.715536","article-title":"Dysbiosis in the human microbiome of cholangiocarcinoma","volume":"12","author":"Rao","year":"2021","journal-title":"Front. Physiol."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40779-022-00423-x","article-title":"Alterations in the human oral microbiome in cholangiocarcinoma","volume":"9","author":"Rao","year":"2022","journal-title":"Mil. Med. Res."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"382","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut Microbes"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"e0247798","DOI":"10.1371\/journal.pone.0247798","article-title":"Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma","volume":"16","author":"Saab","year":"2021","journal-title":"PLoS One"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/01635581.2024.2367266","article-title":"Exploring the relationship between diet, lifestyle and gut microbiome in colorectal cancer development: a recent update","volume":"76","author":"Saha","year":"2024","journal-title":"Nutr. Cancer"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12915-014-0087-z","article-title":"Reagent and laboratory contamination can critically impact sequence-based microbiome analyses","volume":"12","author":"Salter","year":"2014","journal-title":"BMC Biol."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/mog.0000000000001013","article-title":"The role of the microbiome in liver disease","volume":"40","author":"Sch\u00f6ler","year":"2024","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/cjp2.151","article-title":"Microbiome applications for pathology: challenges of low microbial biomass samples during diagnostic testing","volume":"6","author":"Selway","year":"2020","journal-title":"J. Pathol. Clin. Res."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and Bacteria cells in the body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol."},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"2113717","DOI":"10.1080\/19490976.2022.2113717","article-title":"Intestinal phages interact with bacteria and are involved in human diseases","volume":"14","author":"Shuwen","year":"2022","journal-title":"Gut Microbes"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2018.09.004","article-title":"Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer","volume":"175","author":"Singh","year":"2018","journal-title":"Cell"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"e13876","DOI":"10.7717\/peerj.13876","article-title":"Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles","volume":"10","author":"Sitthirak","year":"2022","journal-title":"PeerJ"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13099-025-00734-z","article-title":"Gut microbiome in gastrointestinal neoplasms: from mechanisms to precision therapeutic strategies","volume":"17","author":"Song","year":"2025","journal-title":"Gut Pathog."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1080\/19490976.2020.1762520","article-title":"The role of gastric microbiota in gastric cancer","volume":"11","author":"Stewart","year":"2020","journal-title":"Gut Microbes"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"2391521","DOI":"10.1080\/19490976.2024.2391521","article-title":"Synergism of Fusobacterium periodonticum and N-nitrosamines promote the formation of EMT subtypes in ESCC by modulating Wnt3a palmitoylation","volume":"16","author":"Sun","year":"2024","journal-title":"Gut Microbes"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1002\/cam4.3206","article-title":"Role of the oral microbiota in cancer evolution and progression","volume":"9","author":"Sun","year":"2020","journal-title":"Cancer Med."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-immunol-090222-102035","article-title":"Microbial metabolites and gut immunology","volume":"42","author":"Takeuchi","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41564-023-01350-w","article-title":"No evidence for a common blood microbiome based on a population study of 9,770 healthy humans","volume":"8","author":"Tan","year":"2023","journal-title":"Nat. Microbiol."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5152\/tjg.2020.19056","article-title":"Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis","volume":"31","author":"Tan","year":"2020","journal-title":"Turk J Gastroenterol"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"108659","DOI":"10.1016\/j.ejso.2024.108659","article-title":"Survival analysis and prognostic nomogram for patients with cholangiocarcinoma after radical resection in Asia","volume":"50","author":"Tang","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"104204","DOI":"10.1016\/j.lpm.2023.104204","article-title":"Fecal microbiota transplantation: history, procedure and regulatory considerations","volume":"52","author":"Thanush","year":"2023","journal-title":"Presse Med."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1136\/gutjnl-2021-326264","article-title":"Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes","volume":"71","author":"Ting","year":"2022","journal-title":"Gut"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1158\/2159-8290.Cd-17-0245","article-title":"New horizons for precision medicine in biliary tract cancers","volume":"7","author":"Valle","year":"2017","journal-title":"Cancer Discov."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000431071","article-title":"Biliary mucosal barrier and microbiome","volume":"31","author":"Verdier","year":"2015","journal-title":"Viszeralmedizin"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41564-019-0483-9","article-title":"Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC\/IBD diagnoses","volume":"4","author":"Vieira-Silva","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"199","DOI":"10.12688\/wellcomeopenres.15628.3","article-title":"Improving causality in microbiome research: can human genetic epidemiology help?","volume":"4","author":"Wade","year":"2019","journal-title":"Wellcome Open Res."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"2236364","DOI":"10.1080\/19490976.2023.2236364","article-title":"Colorectal cancer and gut microbiota studies in China","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Microbes"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","article-title":"Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"e2500481","DOI":"10.1002\/adma.202500481","article-title":"Fast encapsulation of microbes into dissolvable hydrogel beads enables high-throughput microbial single-cell RNA sequencing of clinical microbiome samples","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"1646897","DOI":"10.3389\/fonc.2025.1646897","article-title":"Targeting the gut-liver axis in cholangiocarcinoma: mechanisms, therapeutic advances, and future directions","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Oncol."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"977","DOI":"10.20892\/j.issn.2095-3941.2024.0240","article-title":"Tumor-related fungi and crosstalk with gut fungi in the tumor microenvironment","volume":"21","author":"Wang","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.csbj.2025.03.030","article-title":"Bile-liver phenotype: exploring the microbiota landscape in bile and intratumor of cholangiocarcinoma","volume":"27","author":"Wang","year":"2025","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"103025","DOI":"10.1016\/j.ctrv.2025.103025","article-title":"Fecal microbiota transplantation to enhance cancer treatment outcomes across different cancer types: a systematic literature review","volume":"140","author":"Wekking","year":"2025","journal-title":"Cancer Treat. Rev."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ajpath.2024.11.004","article-title":"Gut microbiome and bile acid interactions: mechanistic implications for cholangiocarcinoma development, immune resistance, and therapy","volume":"195","author":"Wu","year":"2025","journal-title":"Am. J. Pathol."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.virs.2024.04.008","article-title":"Ten computational challenges in human virome studies","volume":"39","author":"Wu","year":"2024","journal-title":"Virol. Sin."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1002\/cphy.c230013","article-title":"The human microbiome-A physiologic perspective","volume":"14","author":"Xiao","year":"2024","journal-title":"Compr. Physiol."},{"key":"ref145","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00535-024-02090-2","article-title":"Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma","volume":"59","author":"Xin","year":"2024","journal-title":"J. Gastroenterol."},{"key":"ref146","doi-asserted-by":"publisher","first-page":"104967","DOI":"10.1016\/j.ebiom.2024.104967","article-title":"Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy","volume":"100","author":"Yang","year":"2024","journal-title":"EBioMedicine"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11102598","article-title":"Interplay between the human microbiome and biliary tract Cancer: implications for pathogenesis and therapy","volume":"11","author":"Ye","year":"2023","journal-title":"Microorganisms"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"e0150519","DOI":"10.1371\/journal.pone.0150519","article-title":"Influence of the biliary system on biliary Bacteria revealed by bacterial communities of the human biliary and upper digestive tracts","volume":"11","author":"Ye","year":"2016","journal-title":"PLoS One"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cell.2019.07.010","article-title":"Benchmarking metagenomics tools for taxonomic classification","volume":"178","author":"Ye","year":"2019","journal-title":"Cell"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"1523863","DOI":"10.3389\/fcimb.2025.1523863","article-title":"Characteristics of gut microbiota and metabolites in extrahepatic cholangiocarcinoma and their prognostic value for resectable lesions","volume":"15","author":"Ye","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref152","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1080\/1040841x.2025.2501590","article-title":"The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma","volume":"51","author":"Yoon","year":"2025","journal-title":"Crit. Rev. Microbiol."},{"key":"ref153","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/cas.16010","article-title":"Oral bacterium Streptococcus mutans promotes tumor metastasis through thrombosis formation","volume":"115","author":"Yu","year":"2024","journal-title":"Cancer Sci."},{"key":"ref155","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1136\/gutjnl-2024-332815","article-title":"Stomach microbiota in gastric cancer development and clinical implications","volume":"73","author":"Zeng","year":"2024","journal-title":"Gut"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"1090392","DOI":"10.3389\/fmicb.2022.1090392","article-title":"Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref157","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/2159-8290.Cd-20-0304","article-title":"Gut microbiome directs hepatocytes to recruit MDSCs and promote cholangiocarcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"751795","DOI":"10.3389\/fcimb.2021.751795","article-title":"A predictive model based on the gut microbiota improves the diagnostic effect in patients with cholangiocarcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref159","doi-asserted-by":"publisher","first-page":"167152","DOI":"10.1016\/j.bbadis.2024.167152","article-title":"Gut microbiota regulates the ALK5\/NOX1 axis by altering glutamine metabolism to inhibit ferroptosis of intrahepatic cholangiocarcinoma cells","volume":"1870","author":"Zhang","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00248-023-02318-3","article-title":"A novel Bifidobacterium\/Klebsiella ratio in characterization analysis of the gut and bile microbiota of CCA patients","volume":"87","author":"Zhang","year":"2023","journal-title":"Microb. Ecol."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.trecan.2021.01.010","article-title":"Gut microbiota in cancer immune response and immunotherapy","volume":"7","author":"Zhou","year":"2021","journal-title":"Trends Cancer"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1727736\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:12:55Z","timestamp":1771924375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1727736\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":161,"alternative-id":["10.3389\/fmicb.2026.1727736"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1727736","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"article-number":"1727736"}}